269 related articles for article (PubMed ID: 37523107)
41. A case report of thrombocytopenic COVID-19 and Miller-Fisher syndrome on a concurrent chronic immune neuropathy.
Blackbourn L; Hamid U; Tokala J; Blume G
Medicine (Baltimore); 2024 May; 103(21):e38304. PubMed ID: 38788032
[TBL] [Abstract][Full Text] [Related]
42. Clinical characteristics and outcomes of patients with Guillain-Barré and acquired CNS demyelinating overlap syndrome: a cohort study based on a literature review.
Mao Z; Hu X
Neurol Res; 2014 Dec; 36(12):1106-13. PubMed ID: 24914906
[TBL] [Abstract][Full Text] [Related]
43. Only anti-GM4 antibody positivity in a Chinese girl with overlapping MFS/GBS: a case report.
Chen J; Tian M; Shu X
Neurol Sci; 2024 May; 45(5):2331-2335. PubMed ID: 38270731
[TBL] [Abstract][Full Text] [Related]
44. Concomitant Guillain-Barré Syndrome and COVID-19: A Meta-Analysis of Cases.
Bentley SA; Ahmad S; Kobeissy FH; Toklu HZ
Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557036
[No Abstract] [Full Text] [Related]
45. Nationwide survey of childhood Guillain-Barré syndrome, Fisher syndrome, and Bickerstaff brainstem encephalitis in Japan.
Fujii K; Shiohama T; Uchida T; Ikehara H; Fukuhara T; Sawada D; Aoyama H; Uchikawa H; Yoshii S; Arahata Y; Shimojo N; Misawa S; Kuwabara S
Brain Dev; 2023 Jan; 45(1):16-25. PubMed ID: 36511273
[TBL] [Abstract][Full Text] [Related]
46. Prediction of disease progression in Miller Fisher and overlap syndromes.
Verboon C; van Berghem H; van Doorn PA; Ruts L; Jacobs BC
J Peripher Nerv Syst; 2017 Dec; 22(4):446-450. PubMed ID: 29065229
[TBL] [Abstract][Full Text] [Related]
47. A case of Miller Fisher syndrome with delayed onset peripheral facial nerve palsy after COVID-19 vaccination: a case report.
Nanatsue K; Takahashi M; Itaya S; Abe K; Inaba A
BMC Neurol; 2022 Aug; 22(1):309. PubMed ID: 35996074
[TBL] [Abstract][Full Text] [Related]
48. Guillain-Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases.
Abu-Rumeileh S; Abdelhak A; Foschi M; Tumani H; Otto M
J Neurol; 2021 Apr; 268(4):1133-1170. PubMed ID: 32840686
[TBL] [Abstract][Full Text] [Related]
49. Classic and overlapping Miller-Fisher syndrome: clinical and electrophysiological features in Mexican adults.
Bazán-Rodríguez L; López-Hernández JC; Jorge de Saráchaga A; Gómez-Figueroa E; Leon-Manriquez E; Briseño-Godinez ME; May-Mas R; Pérez-Valdez EY; Pérez-Jovel E; Vargas-Cañas S
Neurol Sci; 2021 Oct; 42(10):4225-4229. PubMed ID: 33594537
[TBL] [Abstract][Full Text] [Related]
50. Miller-Fisher syndrome after COVID-19: neurochemical markers as an early sign of nervous system involvement.
Senel M; Abu-Rumeileh S; Michel D; Garibashvili T; Althaus K; Kassubek J; Otto M
Eur J Neurol; 2020 Nov; 27(11):2378-2380. PubMed ID: 32781484
[TBL] [Abstract][Full Text] [Related]
51. Diagnosis of Guillain-Barré syndrome and validation of the Brighton criteria in Malaysia.
Tan CY; Razali SNO; Goh KJ; Shahrizaila N
J Peripher Nerv Syst; 2020 Sep; 25(3):256-264. PubMed ID: 32511817
[TBL] [Abstract][Full Text] [Related]
52. Cytoalbuminologic dissociation in Asian patients with Guillain-Barré and Miller Fisher syndromes.
Wong AH; Umapathi T; Nishimoto Y; Wang YZ; Chan YC; Yuki N
J Peripher Nerv Syst; 2015 Mar; 20(1):47-51. PubMed ID: 25640907
[TBL] [Abstract][Full Text] [Related]
53. Additional Steroid Therapy for Delayed Facial Palsy in Miller Fisher Syndrome.
Watanabe S; Tokuhara Y; Hiratsuka M; Yoshizumi K; Ukon S; Kasama S; Takeda M; Funakoshi K; Kimura T
Intern Med; 2022; 61(22):3435-3438. PubMed ID: 36385049
[TBL] [Abstract][Full Text] [Related]
54. Ataxic Guillain-Barré syndrome with anti-GQ1b antibody: relation to Miller Fisher syndrome.
Yuki N; Susuki K; Hirata K
Neurology; 2000 May; 54(9):1851-3. PubMed ID: 10802797
[TBL] [Abstract][Full Text] [Related]
55. [Clinical analyses of recurrence in Guillain-Barré syndrome and Fisher syndrome].
Neshige S; Yoshimoto T; Takeshima S; Himeno T; Shimoe Y; Takamatsu K; Kuriyama M
Rinsho Shinkeigaku; 2014; 54(7):577-80. PubMed ID: 25087560
[TBL] [Abstract][Full Text] [Related]
56. A rare mimic of acute stroke: rapidly progressing Miller-Fisher Syndrome to acute motor and sensory axonal neuropathy variant of Guillain-Barre Syndrome.
de Castillo LLC; Diestro JDB; Ignacio KHD; Pasco PMD
BMJ Case Rep; 2019 Mar; 12(3):. PubMed ID: 30936342
[TBL] [Abstract][Full Text] [Related]
57. Miller Fisher syndrome possibly related to mycoplasma pneumoniae infection: report of one case.
Hsueh KC; Chou IC; Hsu CH; Kuo HT; Tsai FJ; Tsai CH
Acta Paediatr Taiwan; 2004; 45(3):168-70. PubMed ID: 15493737
[TBL] [Abstract][Full Text] [Related]
58. How often and when Fisher syndrome is overlapped by Guillain-Barré syndrome or Bickerstaff brainstem encephalitis?
Sekiguchi Y; Mori M; Misawa S; Sawai S; Yuki N; Beppu M; Kuwabara S
Eur J Neurol; 2016 Jun; 23(6):1058-63. PubMed ID: 26969889
[TBL] [Abstract][Full Text] [Related]
59. Guillain-Barré syndrome in children - High occurrence of Miller Fisher syndrome in East Asian region.
Chiu ATG; Chan RWK; Yau MLY; Yuen ACL; Lam AKF; Lau SWY; Lau AMC; Fung STH; Ma KH; Lau CWL; Yau MM; Ko CH; Tsui KW; Ma CK; Tai SM; Yau EKC; Fung E; Wu SP; Kwong KL; Chan SHS
Brain Dev; 2022 Nov; 44(10):715-724. PubMed ID: 35906115
[TBL] [Abstract][Full Text] [Related]
60. COVID-19-associated serum and cerebrospinal fluid cytokines in post- versus para-infectious SARS-CoV-2-related Guillain-Barré syndrome.
Massa F; Vigo T; Bellucci M; Giunti D; Emanuela MM; Visigalli D; Capodivento G; Cerne D; Assini A; Boni S; Rizzi D; Narciso E; Grisanti GS; Coco E; Uccelli A; Schenone A; Franciotta D; Benedetti L
Neurol Sci; 2024 Mar; 45(3):849-859. PubMed ID: 38169013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
